558 | 1 | 297 |
下载次数 | 被引频次 | 阅读次数 |
明确天山堇菜提取物的抗甲型H1N1流感病毒药效,探索其免疫调节的作用机制。采取甲型H1N1感染小鼠致肺炎模型,分为正常组、模型组、达菲组、天山堇菜提取物320、160、80 mg·kg-1剂量组,检测肺指数、肺组织病毒载量、肺组织中免疫因子、脾组织中免疫细胞Th1/Th2、Th17/Treg比例、脾组织中NK细胞百分比和激活量;进行肺部病理学观察。与正常组比较,模型组小鼠肺指数显著升高(P<0.01);病毒载量显著上升(P<0.01);TNF-α、TGF-β含量显著升高(P<0.01),IL-17A、IFN-γ有升高趋势但无统计学差异,IL-12基本无差别;Th1/Th2比例显著升高(P<0.05),Th17/Treg有降低趋势,但无显著性差异;脾组织中总NK细胞百分比显著升高(P<0.01)、活化的NK细胞占比显著升高(P<0.05);肺组织间质出现大范围的炎症渗出,伴随明显的瘀血现象,且肺组织间质有粘液渗出。与模型组比较,天山堇菜提取物能够显著降低小鼠肺指数(P<0.05);降低小鼠肺组织中病毒载量(P<0.01);降低TNF-α和TGF-β含量,升高IL-17A、IFN-γ和IL-12含量(P<0.01);增加活化NK细胞数量(P<0.01);并能够改善肺组织病变情况。天山堇菜提取物能够通过减轻肺部损伤、降低病毒载量、抑制炎症反应、调节关键细胞因子以及激活免疫细胞等多重机制发挥抗甲型H1N1流感病毒感染的作用。
Abstract:To clarify the anti-influenza A(H1N1) effect of Viola tianshanica Maxim extract and explore its immunomodulatory mechanism. The mouse pneumonia model induced d by H1N1 infection was divided into normal group, model group, Tamiflu group, and Viola tianshanica Maxim extract 320, 160, and 80 mg·kg-1dose groups. The lung index, viral load in lung tissue, immune factors in lung tissue, immune cell Th1/Th2, Th17/Treg ratio in spleen tissue, total amount and activation of NK cells in spleen tissue were detected; lung pathologic change was observed. Compared with the normal group, the lung index of mice in the model group was significantly increased(P<0.01); the viral load was significantly increased(P<0.01); the contents of TNF-α and TGF-β were significantly increased(P<0.01)., IL-17A and IFN-γ tended to increase but there was no statistical difference. IL-12 basically showed no difference. The ratio of Th1/Th2 increased significantly(P<0.05), and Th17/Treg showed a decreasing trend but no significant difference. The total NK cell amount in the spleen tissue increased significantly(P<0.01), and the activated NK cell content increased significantly(P<0.05). There was a large-scale inflammatory infiltration in the interstitium of the lung tissue, accompanied by obvious stasis. There is bleeding phenomenon, and there is mucus exudation in the interstitium of the lung tissue. Compared with the model group, Viola tianshanica Maxim extract can significantly reduce the lung index of mice(P<0.05); reduce the viral load in mouse lung tissue(P<0.01); reduce the contents of TNF-α and TGF-β, and increase IL-17A, IFN-γ and IL-12 contents(P<0.01). It can increase the number of activated NK cells(P<0.01), and improve lung tissue lesions. Viola tianshanica Maxim extract exerts anti-influenza A(H1N1) virus infection through multiple mechanisms such as reducing lung damage, reducing viral load, inhibiting inflammatory response, regulating key cytokines, and activating immune cells.
[1] Bautista E, Chotpitayasunondh T, et al. Clinical aspects of pandemic 2009 influenza A(H1N1)virus infection[J]. N Engl J Med, 2010, 362(18):1708-1719. DOI:10. 1056/nejmra1000449.
[2] Zhang B, Xu S, Liu M, et al. The nucleoprotein of influenza A virus inhibits the innate immune response by inducing mitophagy[J]. Autophagy, 2023, 19(7):1916-1933. DOI:10. 1080/15548627. 2022. 2162798.
[3] Wang X, Yang QL, Shi YZ, et al. Protective effects of the ethanol extract of Viola tianshanica maxim against acute lung injury induced by lipopolysaccharides in mice[J]. J Microbiol Biotechnol, 2017, 27(9):1628-1638.DOI:10. 4014/jmb. 1701. 01067.
[4]王雪,司丽君,刘燕,等.天山堇菜总黄酮抗炎和免疫调节作用研究[J].中药药理与临床,2021, 37(2):49-54. DOI:10. 13412/j. cnki. zyyl. 2021. 02. 004.
[5]王雪,史玉柱,司丽君,等.天山堇菜总黄酮抗甲型流感病毒的作用研究[J].中药新药与临床药理,2020,31(6):655-661. DOI:10. 19378/j. issn. 1003-9783. 2020. 06. 006.
[6] Zhang W, Xu H, Guan S, et al. Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic[J]. J Med Virol, 2022, 94(9):4406-4416. DOI:10. 1002/jmv. 27870.
[7] Lee D, Jo H, Jang Y, et al. Alloferon and zanamivir show effective antiviral activity against influenza A virus(H1N1)infection in vitro and in vivo[J]. Int J Mol Sci.2022, 24(1):678. DOI:10. 3390/ijms24010678.
[8] Savenkova DA, Gudymo AS, Korablev AN, et al.Knockout of the tnfa gene decreases influenza virusinduced histological reactions in laboratory mice[J]. Int J Mol Sci, 2024, 25(2):1156. DOI:10. 3390/ijms25021156.
[9] Hagau N, Slavcovici A, Gonganau DN, et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection[J]. Crit Care, 2010, 14(6):R203.DOI:10. 1186/cc9324.
[10]Li C, Yang P, Sun Y, et al. IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A(H1N1)Virus[J]. Cell Res, 2012, 22(3):528-538. DOI:10. 1038/cr. 2011. 165.
[11]唐源,祝洁,杨小余,等.人β防御素3和γ干扰素在MAPK信号通路中的相互诱导及联合抗甲型流感病毒的机制[J].贵州医科大学学报,2023, 48(4):373-382. DOI:10. 19367/j. cnki. 2096-8388. 2023. 04. 001.
[12]潘宸,胡精蕴,张岩威,等.甲型流感病毒通过调控TGF-β1介导的ORM2抑制CCL3表达[J].中国兽医科学,2022, 52(10):1308-1316. DOI:10. 16656/j.issn. 1673-4696. 2022. 0170.
[13]BustosRivera-Bahena G, López-Guerrero DV,Márquez-Bandala AH, et al. TGF-β1 signaling inhibit the in vitro apoptotic, infection and stimulatory cell response induced by influenza H1N1 virus infection on A549 cells[J]. Virus Res, 2021, 297:198337. DOI:10. 1016/j. virusres. 2021. 198337.
[14]Harvey AG, Graves AM, Uppalapati CK, et al.Dendritic cell-natural killer cell cross-talk modulates T cell activation in response to influenza A viral infection[J]. Front Immunol, 2022, 13:1006998. DOI:10. 3389/fimmu. 2022. 1006998.
[15]Tsang TK, Lam KT, Liu Y, et al. Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study[J]. BMC Med,2022, 20(1):230. DOI:10. 1186/s12916-022-02429-7.
[16]Shi C, Zhou L, Li H, et al. Intestinal microbiota metabolizing houttuynia cordata polysaccharides in H1N1 induced pneumonia mice contributed to Th17/Treg rebalance in gut-lung axis[J]. Int J Biol Macromol. 2022, 221∶288-302. DOI:10. 1016/j.ijbiomac. 2022. 09. 015.
[17]Hornick EE, Zacharias ZR, Legge KL. Kinetics and phenotype of the CD4 T cell response to influenza virus infections[J]. Front Immunol, 2019, 10:2351. DOI:10. 3389/fimmu. 2019. 02351.
[18]Zheng J, Wen L, Yen HL, et al. Phenotypic and functional characteristics of a novel influenza virus hemagglutinin-specific memory NK cell[J]. J Virol,2021, 95(12):e00165-e00121. DOI:10. 1128/jvi. 00165-21.
基本信息:
DOI:10.13242/j.cnki.bingduxuebao.004531
中图分类号:R285.5
引用信息:
[1]包蕾,刘燕,耿子涵等.天山堇菜提取物对甲型H1N1流感病毒感染小鼠的抗病毒及免疫调节作用研究[J].病毒学报,2024,40(04):695-704.DOI:10.13242/j.cnki.bingduxuebao.004531.
基金信息:
新疆维吾尔自治区自然科学基金杰出青年科学基金:(项目号:2021D01E26),题目:基于Toll样受体3/7(TRL3/7)、维甲酸诱导基因1(RIG-1)受体探讨天山革菜总黄酮对流感病毒感染引起宿主细胞固有免疫应答的调控机制; 自治区创新环境(人才、基地)建设专项:(项目号:PT2305),题目:地产中药民族药活性筛选、药效评价及机制研究平台建设~~